Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults - Quiz - MDSpire

Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults

  • By

  • Sara Y Tartof

  • Timothy B Frankland

  • Jeff M Slezak

  • Bradley K Ackerson

  • Laura Puzniak

  • January 15, 2026

  • 0 min

Share

Original Source(s)

Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults

  • by Sara Y Tartof, Timothy B Frankland, Jeff M Slezak, Bradley K Ackerson, Laura Puzniak

  • January 15, 2026

Related Content

The latest developments on Ebola, hepatitis B, long Covid

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Permanent hypoparathyroidism following SARS-CoV-2 infection: a case report with two-year follow-up and literature review